Literature DB >> 18158248

Synthesis, analgesic, anti-inflammatory, and antimicrobial activity of some novel pyrimido[4,5-b]quinolin-4-ones.

Abdel-Rahman B A El-Gazzar1, Mervat M El-Enany, Mahmoud N Mahmoud.   

Abstract

Novel series of pyrimido[4,5-b]quinolines (3a-c), triazolo[4',3':1,2]pyrimido[4,5-b]-quinolines (7a-e, 9, and 14), tetrazolo[4',3':1,2]pyrimido[4,5-b]quinolin-5-one (13), [1,3]-pyrazolo[3',2':1,2]pyrimido[4,5-b]quinolines (12a and 12b), and 2-pyrazolyl-pyrimido[4,5-b]-quinolines (15, 16a, 16b, and 19) have been synthesized. Some of the new compounds were tested against various bacteria and fungi species. In addition, the analgesic and anti-inflammatory activities are reported. Compounds 8 and 9a possess high activity toward the fungi as compared with the reference drug Nystatin. The tested compounds 5 and 8 have moderate anti-inflammatory activities. Moreover compounds 5, 8, 10, and 16a, have activities higher than the reference drug in peripheral analgesic activity testing, Compounds 5, 7a, 11a, and 16a have potencies as the reference drug in central analgesic activity testing.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18158248     DOI: 10.1016/j.bmc.2007.12.012

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  3 in total

1.  Novel pyranopyrazoles: synthesis and theoretical studies.

Authors:  Ahmed A Al-Amiery; Redah I Al-Bayati; Fouad M Saed; Wassan B Ali; Abdul Amir H Kadhum; Abu Bakar Mohamad
Journal:  Molecules       Date:  2012-08-30       Impact factor: 4.411

2.  Synthesis of new visnagen and khellin furochromone pyrimidine derivatives and their anti-inflammatory and analgesic activity.

Authors:  Ameen Ali Abu-Hashem; Mohamed M Youssef
Journal:  Molecules       Date:  2011-02-25       Impact factor: 4.411

3.  Retro Diels Alder protocol for regioselective synthesis of novel [1,2,4]triazolo[4,3-a]pyrimidin-7(1H)-ones.

Authors:  Awad I Said; Márta Palkó; Matti Haukka; Ferenc Fülöp
Journal:  RSC Adv       Date:  2020-09-14       Impact factor: 4.036

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.